Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging
Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.
Type 2 Diabetes
TYPE 2 DIABETES
-
-
In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D
Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes. -
Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?
Updated meta-analysis confirms the association between antidepressant drug (AD) use and incident diabetes. Future studies should be aimed at evaluating the effect of single AD on the risk of developing T2D. -
Addressing Psychological Insulin Resistance in Patients With Diabetes
Learn about strategies to reduce a patient’s reluctance to initiate insulin therapy, a phenomenon called psychological insulin resistance.
Video
Latest News
Plasma Copeptin Level Linked to Lower-Extremity Amputations in Diabetes
Researchers assessed whether plasma copeptin, a surrogate marker of vasopressin, is associated with lower-extremity amputation in diabetes.
Less Than 6 Hours of Sleep Increases Risk for Early Death in Patients With Comorbidities
Risk for dying from heart attack, stroke twofold higher among those with high BP, diabetes and short sleep
Dapagliflozin Receives FDA Approval for Reducing Heart Failure Hospitalization Risk
Farxiga has been approved to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.
Risk for Hospitalization With Influenza Higher for Patients With T2D
The risk for hospitalization with pandemic influenza is higher for patients with type 2 diabetes than for those without type 2 diabetes.
Poor Glycemic Control in T2D May Increase Risk for Stroke, Death
Poor glycemic control is associated with increased risks for stroke and death among patients with type 2 diabetes.
Weight Loss Maintenance Important for Cardiometabolic Risk Control in T2D
A larger percentage of weight loss regained after an intensive lifestyle intervention was positively associated with certain cardiometabolic risk factors in type 2 diabetes.
Meta-Analysis: SGLT2 Inhibitors Protect Against Kidney Disease in T2D
A class of diabetes drugs, called sodium-glucose co-transporter-2 inhibitors, protect against kidney disease in patients with type 2 diabetes.
Elevated FGF23 Linked to Mortality in Type 2 Diabetes
In a study, elevated FGF23 was associated with increased risks of major adverse cardiovascular events and mortality in type 2 diabetes patients with normal or mildly impaired kidney function.
Risk Tool Can Predict Heart Failure in Patients With Diabetes
A novel machine learning-derived risk score can predict the risk for heart failure among outpatients with type 2 diabetes.
Increasing Intake of Any Sugary Drink Raises Risk for Diabetes
People who increase their consumption of sweet beverages — either fruit juice or drinks with added sugars — are at greater risk over time for developing diabetes.
Want to read more?
Please login or register first to view this content.
Next post in Type 2 Diabetes
